Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.550
0.00 (0.00%)
At close: Feb 8, 2026
4.73% (1Y)
| Market Cap | 11.63M +7.6% |
| Revenue (ttm) | 9.11M +1.8% |
| Net Income | 913.26K +9.1% |
| EPS | 0.12 +9.1% |
| Shares Out | 7.50M |
| PE Ratio | 12.73 |
| Forward PE | n/a |
| Dividend | 0.07 (4.52%) |
| Ex-Dividend Date | Feb 26, 2025 |
| Volume | 1,950 |
| Average Volume | 300 |
| Open | 1.550 |
| Previous Close | n/a |
| Day's Range | 1.550 - 1.550 |
| 52-Week Range | 1.360 - 1.700 |
| Beta | -0.04 |
| RSI | 51.92 |
| Earnings Date | Feb 9, 2026 |